These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 19055746)

  • 1. MFS transportome of the human pathogenic yeast Candida albicans.
    Gaur M; Puri N; Manoharlal R; Rai V; Mukhopadhayay G; Choudhury D; Prasad R
    BMC Genomics; 2008 Dec; 9():579. PubMed ID: 19055746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The drug:H⁺ antiporters of family 2 (DHA2), siderophore transporters (ARN) and glutathione:H⁺ antiporters (GEX) have a common evolutionary origin in hemiascomycete yeasts.
    Dias PJ; Sá-Correia I
    BMC Genomics; 2013 Dec; 14():901. PubMed ID: 24345006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complete inventory of ABC proteins in human pathogenic yeast, Candida albicans.
    Gaur M; Choudhury D; Prasad R
    J Mol Microbiol Biotechnol; 2005; 9(1):3-15. PubMed ID: 16254441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-wide expression profiling of the response to terbinafine in Candida albicans using a cDNA microarray analysis.
    Zeng YB; Qian YS; Ma L; Gu HN
    Chin Med J (Engl); 2007 May; 120(9):807-13. PubMed ID: 17531123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic landscape of the DHA1 family in Candida auris and mapping substrate repertoire of CauMdr1.
    Khatoon R; Sharma S; Vishwakarma P; Saini A; Aggarwal P; Lynn AM; Prakash A; Prasad R; Banerjee A
    Appl Microbiol Biotechnol; 2022 Nov; 106(21):7085-7097. PubMed ID: 36184687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and phylogenetic analysis of a glucose transporter gene family from the human pathogenic yeast Candida albicans.
    Fan J; Chaturvedi V; Shen SH
    J Mol Evol; 2002 Sep; 55(3):336-46. PubMed ID: 12187386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Candida Efflux ATPases and Antiporters in Clinical Drug Resistance.
    Prasad R; Rawal MK; Shah AH
    Adv Exp Med Biol; 2016; 892():351-376. PubMed ID: 26721282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Classification of all putative permeases and other membrane plurispanners of the major facilitator superfamily encoded by the complete genome of Saccharomyces cerevisiae.
    Nelissen B; De Wachter R; Goffeau A
    FEMS Microbiol Rev; 1997 Sep; 21(2):113-34. PubMed ID: 9348664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MFS transporters of Candida species and their role in clinical drug resistance.
    K Redhu A; Shah AH; Prasad R
    FEMS Yeast Res; 2016 Jun; 16(4):. PubMed ID: 27188885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of Candida albicans CDR1, CDR2, or MDR1 does not produce significant changes in echinocandin susceptibility.
    Niimi K; Maki K; Ikeda F; Holmes AR; Lamping E; Niimi M; Monk BC; Cannon RD
    Antimicrob Agents Chemother; 2006 Apr; 50(4):1148-55. PubMed ID: 16569823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Divergent functions of three Candida albicans zinc-cluster transcription factors (CTA4, ASG1 and CTF1) complementing pleiotropic drug resistance in Saccharomyces cerevisiae.
    Coste AT; Ramsdale M; Ischer F; Sanglard D
    Microbiology (Reading); 2008 May; 154(Pt 5):1491-1501. PubMed ID: 18451058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular cloning and functional characterisation of a glucose transporter, CaHGT1, of Candida albicans.
    Varma A; Singh BB; Karnani N; Lichtenberg-Fraté H; Höfer M; Magee BB; Prasad R
    FEMS Microbiol Lett; 2000 Jan; 182(1):15-21. PubMed ID: 10612724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms.
    Sanglard D; Coste AT
    Antimicrob Agents Chemother; 2016 Jan; 60(1):229-38. PubMed ID: 26482310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A family of oligopeptide transporters is required for growth of Candida albicans on proteins.
    Reuss O; Morschhäuser J
    Mol Microbiol; 2006 May; 60(3):795-812. PubMed ID: 16629678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolution of the 12-spanner drug:H+ antiporter DHA1 family in hemiascomycetous yeasts.
    Dias PJ; Seret ML; Goffeau A; Correia IS; Baret PV
    OMICS; 2010 Dec; 14(6):701-10. PubMed ID: 21114408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ABCs of Candida albicans Multidrug Transporter Cdr1.
    Prasad R; Banerjee A; Khandelwal NK; Dhamgaye S
    Eukaryot Cell; 2015 Dec; 14(12):1154-64. PubMed ID: 26407965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ABC transporter Cdr1p contributes more than Cdr2p does to fluconazole efflux in fluconazole-resistant Candida albicans clinical isolates.
    Holmes AR; Lin YH; Niimi K; Lamping E; Keniya M; Niimi M; Tanabe K; Monk BC; Cannon RD
    Antimicrob Agents Chemother; 2008 Nov; 52(11):3851-62. PubMed ID: 18710914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Azole Resistance Reduces Susceptibility to the Tetrazole Antifungal VT-1161.
    Monk BC; Keniya MV; Sabherwal M; Wilson RK; Graham DO; Hassan HF; Chen D; Tyndall JDA
    Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30397057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multidrug transporters of Candida species in clinical azole resistance.
    Prasad R; Nair R; Banerjee A
    Fungal Genet Biol; 2019 Nov; 132():103252. PubMed ID: 31302289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Candida albicans Clinical Isolates from a Southwest Brazilian Tertiary Hospital Exhibit MFS-mediated Azole Resistance Profile.
    Pinto ACC; Rocha DAS; Moraes DC; Junqueira ML; Ferreira-Pereira A
    An Acad Bras Cienc; 2019 Jul; 91(3):e20180654. PubMed ID: 31365653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.